Folate-vitamin B12 interrelationships: Links to disease risk

Folate in Health and Disease, Second Edition

Volumn , Issue , 2009, Pages 381-408

  Molloy, Anne M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954552237     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (228)

1. Keller EB, Rachele JR, Du Vigneaud V. A study of transmethylation with methionine containing deuterium and C14 in the methyl group. J Biol Chem 1949; 177:733-38.
2. Rachele JR, Reed LJ, Kidwai AR, Ferger MF, du Vigneaud V. Conversion of cystathionine labeled with S35 to cystine in vivo. J Biol Chem 1950; 185:817-26.
3. du Vigneaud V, Ressler C, Rachele JR. The biological synthesis of “labile methyl group.”Science 1950; 112:267-71.
4. Bennett MA. Utilization of homocystine for growth in presence of vitamin B12 and folic acid. J Biol Chem 1950; 187:751-56.
5. Weissbach H, Taylor RT. Roles of vitamin B 12 and folic acid in methionine synthesis. Vitam Horm 1970; 28:415-40.
6. Matthews RG. Cobalamin-dependent methionine synthase. In: Banerjee R, ed., Chemistry and Biochemistry of B12. New York: John Wiley and Sons, Inc, 1999:681-706.
7. Evans JC, Huddler DP, Hilgers MT, Romanchuk G, Matthews RG, Ludwig ML. Structures of the N-terminal modules imply large domain motions during catalysis by methionine synthase. Proc Natl Acad Sci USA 2004; 101:3729-36.
8. Taylor RT, Weissbach H. N5-Methyltetrahydrofolate-homocysteine transmethylase. Partial purification and properties. J Biol Chem 1967; 242:1502-08.
9. Taylor RT, Weissbach H. N5-Methyltetrahydrofolate-homocysteine transmethylase. Role of S-adenosylmethionine in vitamin B12-dependent methionine synthesis. J Biol Chem 1967; 242:1517-21.
10. Taylor RT, Weissbach H. N5-Methyltetrahydrofolate-homocysteine transmethylase. Propylation characteristics with the use of a chemical reducing system and purified enzyme. J Biol Chem 1967; 242:1509-16.
11. Taylor RT, Weissbach H. Escherichia coli B N5-methyltetrahydrofolate-homocysteine cobalamin methyltransferase: Activation with S-adenosyl-L-methionine and the mechanism for methyl group transfer. Arch Biochem Biophys 1969; 129:745-66.
12. Goulding CW, Postigo D, Matthews RG. Cobalamin-dependent methionine synthase is a modular protein with distinct regions for binding homocysteine, methyltetrahydrofolate, cobalamin, and adenosylmethionine. Biochemistry 1997; 36:8082-91.
13. Jarrett JT, Hoover DM, Ludwig ML, Matthews RG. The mechanism of adenosyl-methionine-dependent activation of methionine synthase: A rapid kinetic analysis of intermediates in reductive methylation of cob(II)alamin enzyme. Biochemistry 1998; 37:12649-58.
14. Bandarian V, Pattridge KA, Lennon BW, Huddler DP, Matthews RG, Ludwig ML. Domain alternation switches B(12)-dependent methionine synthase to the activation conformation. Nat Struct Biol 2002; 9:53-56.
15. Datta S, Koutmos M, Pattridge KA, Ludwig ML, Matthews RG. A disulfide-stabilized conformer of methionine synthase reveals an unexpected role for the histidine ligand of the cobalamin cofactor. Proc Natl Acad Sci USA 2008; 105: 4115-20.
16. Leclerc D, Odievre M, Wu Q, Wilson A, Huizenga JJ, Rozen R, Scherer SW, Gravel RA. Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. Gene 1999; 240:75-88.
17. Olteanu H, Banerjee R. Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem 2001; 276:35558-63.
18. Yamada K, Gravel RA, Toraya T, Matthews RG. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc Natl Acad Sci USA 2006; 103:9476-81.
19. Leal NA, Olteanu H, Banerjee R, Bobik TA. Human ATP:Cob(I)alamin adenosyl-transferase and its interaction with methionine synthase reductase. J Biol Chem 2004; 279:47536-42.
20. Wolthers KR, Lou X, Toogood HS, Leys D, Scrutton NS. Mechanism of coenzyme binding to human methionine synthase reductase revealed through the crystal structure of the FNR-like module and isothermal titration calorimetry. Biochemistry 2007; 46:11833-44.
21. Li YN, Gulati S, Baker PJ, Brody LC, Banerjee R, Kruger WD. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet 1996; 5:1851-58.
22. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase. cDNA cloning, gene localization, and expression. J Biol Chem 1997; 272:3628-34.
23. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R, Gravel RA. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 1996; 5:1867-74.
24. Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematol Am Soc Hematol Educ Prog 2003:62-81.
25. Watkins D, Ru M, Hwang HY, Kim CD, Murray A, Philip NS, Kim W, et al.Hyperhomocysteinemia due to methionine synthase deficiency, cblG: Structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L. Am J Hum Genet 2002; 71:143-53.
26. Wilson A, Leclerc D, Saberi F, Campeau E, Hwang HY, Shane B, Phillips JA 3rd, Rosenblatt DS, Gravel RA. Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency. Am J Hum Genet 1998; 63:409-14.
27. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HH, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998; 95:3059-64.
28. Wilson A, Leclerc D, Rosenblatt DS, Gravel RA. Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Hum Mol Genet 1999; 8:2009-16.
29. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel RA, Rozen R. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999; 67:317-23.
30. Wang XL, Cai H, Cranney G, Wilcken DE. The frequency of a common mutation of the methionine synthase gene in the Australian population and its relation to smoking and coronary artery disease. J Cardiovasc Risk 1998; 5:289-95.
31. Morita H, Kurihara H, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Yazaki Y. Polymorphism of the methionine synthase gene: Association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arterioscler Thromb Vasc Biol 1999; 19:298-302.
32. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, Peng K, Shane B, Evans AE, Whitehead AS. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999; 17:298-309.
33. Dekou V, Gudnason V, Hawe E, Miller GJ, Stansbie D, Humphries SE. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemost 2001; 85:67-74.
34. Chen J, Stampfer MJ, Ma J, Selhub J, Malinow MR, Hennekens CH, Hunter DJ. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001; 154:667-72.
35. Zhang Y, Zhang M, Niu T, Xu X, Zhu G, Huo Y, Chen C, et al. D919G polymorphism of methionine synthase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients. J Hum Genet 2004; 49:296-301.
36. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:2509-16.
37. Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, et al.Neural tube defects and folate pathway genes: Family-based association tests of genegene and gene-environment interactions. Environ Health Perspect 2006; 114:1547-52.
38. Tsai MY, Welge BG, Hanson NQ, Bignell MK, Vessey J, Schwichtenberg K, Yang F, Bullemer FE, Rasmussen R, Graham KJ. Genetic causes of mild hyperhomocysteine-mia in patients with premature occlusive coronary artery diseases. Atherosclerosis 1999; 143:163-70.
39. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, Tawn EJ, Burn J. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 2004; 41:256-60.
40. Doolin MT, Barbaux S, McDonnell M, Hoess K, Whitehead AS, Mitchell LE. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 2002; 71:1222-26.
41. Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Guéant JL. Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 2003; 121A:219-24.
42. Jacques PF, Bostom AG, Selhub J, Rich S, Ellison RC, Eckfeldt JH, Gravel RA, Rozen R, National Heart, Lung and Blood Institute, National Institutes of Health. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 2003; 166:49-55.
43. Klerk M, Lievers KJ, Kluijtmans LA, LA, Blom HJ, den Heijer M, Schouten EG, Kok FJ, Verhoef P. The 2756A>G variant in the gene encoding methionine synthase: Its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res 2003; 110:87-91.
44. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, Zhu H, Andreussi L, Cama A, Capra V. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 2002; 47:319-24.
45. Yang QH, Botto LD, Gallagher M, Friedman JM, Sanders CL, Koontz D, Nikolova S, Erickson JD, Steinberg K. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: Findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr 2008; 88:232-46.
46. Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 2007; 28:856-65.
47. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis2001; 157:451-56.
48. Zhu H, Wicker NJ, Shaw GM, Lammer EJ, Hendricks K, Suarez L, Canfield M, Finnell RH. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 2003; 78:216-21.
49. Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, Quinlivan EP, Gregory JF 3rd, Theriaque DW, Kauwell GP. Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant. J Nutr 2004; 134:2985-90.
50. O’Leary VB, Mills JL, Pangilinan F, Kirke PN, Cox C, Conley M, Weiler A, et al.Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab 2005; 85:220-27.
51. O’Leary VB, Parle-McDermott A, Molloy AM, Kirke PN, Johnson Z, Conley M, Scott JM, Mills JL. MTRR and MTHFR polymorphism: Link to Down syndrome? Am J Med Genet 2002; 107:151-55.
52. Daubner SC, Matthews RG. Purification and properties of methylenetetrahydrofolate reductase from pig liver. J Biol Chem 1982; 257:140-45.
53. Matthews RG, Vanoni MA, Hainfeld JF, Wall J. Methylenetetrahydrofolate reductase. Evidence for spatially distinct subunit domains obtained by scanning transmission electron microscopy and limited proteolysis. J Biol Chem 1984; 259:11647-50.
54. Kutzbach C, Stokstad EL. Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine. Biochim Biophys Acta1971; 250:459-77.
55. Yamada K, Strahler JR, Andrews PC, Matthews RG. Regulation of human methyl-enetetrahydrofolate reductase by phosphorylation. Proc Natl Acad Sci USA 2005; 102:10454-59.
56. Green JM, Ballou DP, Matthews RG. Examination of the role of methylenetetrahydro-folate reductase in incorporation of methyltetrahydrofolate into cellular metabolism. FASEB J 1988; 2:42-47.
57. Rosenblatt DS, Cooper BA, Lue-Shing S, Wong PW, Berlow S, Narisawa K, Baumgartner R. Folate distribution in cultured human cells. Studies on 5,10-CH2-H4PteGlu reductase deficiency. J Clin Invest 1979; 63:1019-25.
58. Erbe RW. Genetic aspects of folate metabolism. Adv Hum Genet 1979; 9:293-354, 367-69.
59. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds., The Metabolic and Molecular Bases of Inherited Disease, 7th ed. New York: McGraw-Hill, 1995:3111-28.
60. Sibani S, Leclerc D, Weisberg IS, O’Ferrall E, Watkins D, Artigas C, Rosenblatt DS, Rozen R. Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD-responsive mutation. Hum Mutat 2003; 21:509-20.
61. Goyette P, Christensen B, Rosenblatt DS, Rozen R. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR. Am J Hum Genet 1996; 59:1268-75.
62. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 1995; 56:1052-59.
63. Chwatko G, Boers GH, Strauss KA, Shih DM, Jakubowski H. Mutations in methyl-enetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J 2007; 21:1707-13.
64. Boss GR, Erbe RW. Decreased rates of methionine synthesis by methylene tetrahydrofo-late reductase-deficient fibroblasts and lymphoblasts. J Clin Invest 1981; 67:1659-64.
65. Surtees R, Leonard J, Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 1991; 338:1550-54.
66. Kang SS, Wong PW, Zhou JM, Sora J, Lessick M, Ruggie N, Grcevich G. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism1988; 37:611-13.
67. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methyl-enetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 1991;48:536-45.
68. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat Genet 1994; 7:195-200.
69. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-13.
70. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 1999; 6:359-65.
71. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 2001; 98:14853-58.
72. Pejchal R, Campbell E, Guenther BD, Lennon BW, Matthews RG, Ludwig ML. Structural perturbations in the Ala --> Val polymorphism of methylenetetrahydrofolate reductase: How binding of folates may protect against inactivation. Biochemistry 2006; 45:4808-18.
73. Jacques PF, Kalmbach R, Bagley PJ, et al. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr2002; 132:283-88.
74. Hustad S, Ueland PM, Vollset SE, Zhang Y, Bjorke-Monsen AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: Effect modification by the methylenetet-rahydrofolate reductase C677T polymorphism. Clin Chem 2000; 46:1065-71.
75. McNulty H, Dowey le RC, Strain JJ, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation 2006; 113:74-80.
76. Lathrop Stern L, Shane B, Bagley PJ, Nadeau M, Shih V, Selhub J. Combined marginal folate and riboflavin status affect homocysteine methylation in cultured immortalized lymphocytes from persons homozygous for the MTHFR C677T mutation. J Nutr 2003; 133:2716-20.
77. McNulty H, McKinley MC, Wilson B, McPartlin J, Strain JJ, Weir DG, Scott JM. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: Implications for riboflavin requirements. Am J Clin Nutr 2002; 76:436-41.
78. Hustad S, Midttun O, Schneede J, Vollset SE, Grotmol T, Ueland PM. The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am J Hum Genet 2007; 80:846-55.
79. D’Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb Haemost 2000; 83:563-70.
80. Bailey LB, Duhaney RL, Maneval DR, Kauwell GP, Quinlivan EP, Davis SR, Cuadras A, Hutson AD, Gregory JF 3rd. Vitamin B-12 status is inversely associated with plasma homocysteine in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms. J Nutr 2002; 132:1872-78.
81. Lavoie A, Tripp E, Hoffbrand AV. The effect of vitamin B12 deficiency on methylfolate metabolism and pteroylpolyglutamate synthesis in human cells. Clin Sci Mol Med 1974; 47:617-30.
82. Chen L, Qi H, Korenberg J, Garrow TA, Choi YJ, Shane B. Purification and properties of human cytosolic folylpoly-gamma-glutamate synthetase and organization, localization, and differential splicing of its gene. J Biol Chem 1996; 271:13077-87.
83. Savage JD, Lindenbaum J. Folate-cobalamin interactions. In: Bailey LB, ed., Folate in Health and Disease. New York: Marcel Dekker, 1995:237-86.
84. Shane B, Stokstad EL. Vitamin B12-folate interrelationships. Annu Rev Nutr 1985; 5:115-41.
85. Herbert V, Zalusky R. Interrelations of vitamin B12 and folic acid metabolism: Folic acid clearance studies. J Clin Invest 1962; 41:1263-76.
86. Noronha JM, Silverman M. On folic acid, vitamin B12, methionine and formiminoglu-tamic acid metabolism. In: Heinrich HD, ed., 2nd European Symposium on Vitamin B12 and Intrinsic Factor. Stuttgart, Germany: Enke, 1962:728-36.
87. Shane B, Watson JE, Stokstad EL. Uptake and metabolism of [3H]folate by normal and by vitamin B-12- and methionine-deficient rats. Biochim Biophys Acta 1977; 497:241-52.
88. Fowler B, Whitehouse C, Wenzel F, Wraith JE. Methionine and serine formation in control and mutant human cultured fibroblasts: Evidence for methyl trapping and characterization of remethylation defects. Pediatr Res 1997; 41:145-51.
89. Hoffbrand AV, Jackson BF. Correction of the DNA synthesis defect in vitamin B12 deficiency by tetrahydrofolate: Evidence in favour of the methyl-folate trap hypothesis as the cause of megaloblastic anaemia in vitamin B12 deficiency. Br J Haematol 1993; 83:643-47.
90. Gutstein S, Bernstein LH, Levy L, Wagner G. Failure of response to N5-methyl-tetrahydrofolate in combined folate and B 12 deficiency. Evidence in support of the “folate trap” hypothesis. Am J Dig Dis 1973; 18:142-46.
91. Baumgartner ER, Stokstad EL, Wick SH, Watson JE, Kusano G. Comparison of folic acid coenzyme distribution patterns in patients with methylenetetrahydrofolate reductase and methionine synthetase deficiencies. Pediatr Res 1985; 19:1288-92.
92. Smulders YM, Smith DE, Kok RM, Teerlink T, Swinkels DW, Stehouwer CD, Jakobs C. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: A case for the methylfolate trap. Br J Haematol 2006; 132:623-29.
93. Fujii K, Nagasaki T, Huennekens FM. Accumulation of 5-methyltetrahydrofolate in cobalamin-deficient L1210 mouse leukemia cells. J Biol Chem 1982; 257:2144-46.
94. Waters AH, Mollin DL. Observations on the metabolism of folic acid in pernicious anaemia. Br J Haematol 1963; 9:319-27.
95. Cooper BA, Lowenstein L. Relative folate deficiency of erythrocytes in pernicious anemia and its correction with cyanocobalamin. Blood 1964; 24:502-21.
96. Chanarin I. The Megaloblastic Anaemias, 3rd ed. Oxford, UK: Blackwell Scientific, 1990.
97. Carmel R, Melnyk S, James SJ. Cobalamin deficiency with and without neurologic abnormalities: Differences in homocysteine and methionine metabolism. Blood 2003; 101:3302-08.
98. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006; 5:949-60.
99. Selhub J, Jacques PF, Bostom AG, Wilson PW, Rosenberg IH. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev 2000; 28:117-45.
100. Selhub J, Jacques PF, Dallal G, Choumenkovitch S, Rogers G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. FoodNutr Bull 2008; 29:S67-73.
101. Stabler SP, Lindenbaum J, Allen RH. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr 1996; 126:1266S-72S.
102. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-98.
103. Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomized trials. Am J Clin Nutr 2005; 82:806-12.
104. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001; 73:613-21.
105. Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC, Li Z. High prevalence of hyper-homocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. J Nutr 2007; 137:407-13.
106. Liaugaudas G, Jacques PF, Selhub J, Rosenberg IH, Bostom AG. Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol 2001; 21:849-51.
107. Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG, Scott JM. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 2002; 359:227-28.
108. Scott JM, Weir DG. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet 1981; 2:337-40.
109. Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW, eds., Homocysteine in Health and Disease. Cambridge, UK: Cambridge University Press, 2001:63-78.
110. Molloy AM, Orsi B, Kennedy DG, Kennedy S, Weir DG, Scott JM. The relationship between the activity of methionine synthase and the ratio of S-adenosylmethionine to S-adenosylhomocysteine in the brain and other tissues of the pig. Biochem Pharmacol1992; 44:1349-55.
111. Weir DG, Molloy AM, Keating JN, Young PB, Kennedy S, Kennedy DG, Scott JM. Correlation of the ratio of S-adenosyl-L-methionine to S-adenosyl-L-homocysteine in the brain and cerebrospinal fluid of the pig: Implications for the determination of this methylation ratio in human brain. Clin Sci (Lond) 1992; 82:93-97.
112. Obeid R, Kostopoulos P, Knapp JP, Kasoha M, Becker G, Fassbender K, Herrmann W. Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid. Clin Chem 2007; 53:326-33.
113. Molloy AM, Weir DG. Homocysteine and the nervous system. In: Carmel R, Jacobsen DW, eds., Homocysteine in Health and Disease. Cambridge, UK: Cambridge University Press, 2001:183-97.
114. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 2001; 74:723-29.
115. Paik WK, Kim S. Protein Methylation. New York: John Wiley &Sons, 1980.
116. Garrow TA. Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase. J Biol Chem 1996; 271:22831-38.
117. Chiuve SE, Giovannucci EL, Hankinson SE, Zeisel SH, Dougherty LW, Willett WC, Rimm EB. The association between betaine and choline intakes and the plasma concentrations of homocysteine in women. Am J Clin Nutr 2007; 86: 1073-81.
118. Melse-Boonstra A, Holm PI, Ueland PM, Olthof M, Clarke R, Verhoef P. Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations. Am J Clin Nutr 2005; 81:1378-82.
119. Ueland PM, Holm PI, Hustad S. Betaine: A key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med 2005; 43:1069-75.
120. Finkelstein JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 2007; 45:1694-99.
121. Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost 2000; 26:219-25.
122. Mudd SH, Cerone R, Schiaffino MC, Fantasia AR, Minniti G, Caruso U, Lorini R, et al. Glycine N-methyltransferase deficiency: A novel inborn error causing persistent isolated hypermethioninaemia. J Inherit Metab Dis 2001; 24:448-64.
123. Mudd SH, Brosnan JT, Brosnan ME, Jacobs RL, Stabler SP, Allen RH, Vance DE, Wagner C. Methyl balance and transmethylation fluxes in humans. Am J Clin Nutr 2007; 85:19-25.
124. Finkelstein JD. The regulation of homocysteine metabolism. In: Graham I, Refsum H, Rosenberg IH, Ueland PM, eds., Homocysteine Metabolism: From Basic Science to Clinical Medicine. Boston: Kluwer Academic Publications, 1997:3-9.
125. Jacobs RL, Stead LM, Devlin C, Tabas I, Brosnan ME, Brosnan JT, Vance DE. Physiological regulation of phospholipid methylation alters plasma homocysteine in mice. J Biol Chem 2005; 280:28299-305.
126. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 2006; 83:5-10.
127. McKeever MP, Weir DG, Molloy A, Scott JM. Betaine-homocysteine methyltransferase: Organ distribution in man, pig and rat and subcellular distribution in the rat. Clin Sci (Lond) 1991; 81:551-56.
128. Sunden SL, Renduchintala MS, Park EI, Miklasz SD, Garrow TA. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys 1997; 345:171-74.
129. Suleiman SA, Spector R. Methionine synthetase in mammalian brain: Function, development and distribution. Life Sci 1980; 27:2427-32.
130. Spector R, Coakley G, Blakely R. Methionine recycling in brain: A role for folates and vitamin B-12. J Neurochem 1980; 34:132-37.
131. Kotb M, Kredich NM. Regulation of human lymphocyte S-adenosylmethionine synthetase by product inhibition. Biochim Biophys Acta 1990; 1039:253-60.
132. Gharib A, Sarda N, Chabannes B, Cronenberger L, Pacheco H. The regional concentrations of S-adenosyl-L-methionine, S-adenosyl-L-homocysteine, and adenosine in rat brain. J Neurochem 1982; 38:810-15.
133. Molloy AM, Weir DG, Kennedy G, Kennedy S, Scott JM. A new high performance liquid chromatographic method for the simultaneous measurement of S-adenosylmethionine and S-adenosylhomocysteine. Concentrations in pig tissues after inactivation of methionine synthase by nitrous oxide. Biomed Chromatogr 1990; 4:257-60.
134. Caudill MA, Wang JC, Melnyk S, Pogribny IP, Jernigan S, Collins MD, Santos-Guzman J, Swendseid ME, Cogger EA, James SJ. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. JNutr 2001; 131:2811-18.
135. Gharib A, Chabannes B, Sarda N, Pacheco H. In vivo elevation of mouse brain S-adenosyl-L-homocysteine after treatment with L-homocysteine. J Neurochem 1983; 40:1110-12.
136. Selley ML. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer’s disease. Neurobiol Aging 2007; 28:1834-39.
137. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275:29318-23.
138. Bogdanski P, Pupek-Musialik D, Dytfeld J, Lacinski M, Jablecka A, Jakubowski H. Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients. Biomed Pharmacother 2008; 62:360-65.
139. Song Z, Zhou Z, Uriarte S, Wang L, Kang YJ, Chen T, Barve S, McClain CJ. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: A possible etiological factor in alcoholic liver disease. Hepatology 2004; 40:989-97.
140. Bergmann S, Shatrov V, Ratter F, Schiemann S, Schulze-Osthoff K, Lehmann V. Adenosine and homocysteine together enhance TNF-mediated cytotoxicity but do not alter activation of nuclear factor-kappa B in L929 cells. J Immunol 1994; 153:1736-43.
141. Ratter F, Gassner C, Shatrov V, Lehmann V. Modulation of tumor necrosis factor-alphamediated cytotoxicity by changes of the cellular methylation state: Mechanism and in vivo relevance. Int Immunol 1999; 11:519-27.
142. Buccellato FR, Miloso M, Braga M, Nicolini G, Morabito A, Pravettoni G, Tredici G, Scalabrino G. Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-alpha-mediated. FASEB J 1999; 13:297-304.
143. Peracchi M, Bamonti Catena F, Pomati M, De Franceschi M, Scalabrino G. Human cobalamin deficiency: Alterations in serum tumour necrosis factor-alpha and epidermal growth factor. Eur J Haematol 2001; 67:123-27.
144. Scalabrino G, Carpo M, Bamonti F, Pizzinelli S, D’Avino C, Bresolin N, Meucci G, Martinelli V, Comi GC, Peracchi M. High tumor necrosis factor-alpha [corrected] levels in cerebrospinal fluid of cobalamin-deficient patients. Ann Neurol 2004; 56:886-90.
145. Capdevila A, Burk RF, Freedman J, Frantzen F, Alfheim I, Wagner C. A simple rapid immunoassay for S-adenosylhomocysteine in plasma. J Nutr Biochem 2007; 18:827-31.
146. Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: Alterations with plasma homocysteine and pyridoxal 5’-phosphate concentrations. Clin Chem 2000; 46:265-72.
147. Stabler SP, Allen RH. Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotope-dilution liquid chromatography-mass spectrometry. Clin Chem 2004; 50:365-72.
148. Gellekink H, van Oppenraaij-Emmerzaal D, van Rooij A, Struys EA, den Heijer M, Blom HJ. Stable-isotope dilution liquid chromatography-electrospray injection tandem mass spectrometry method for fast, selective measurement of S-adenosylmethionine and S-adenosylhomocysteine in plasma. Clin Chem 2005; 51:1487-92.
149. Loehrer FM, Haefeli WE, Angst CP, Browne G, Frick G, Fowler B. Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomo-cysteine in plasma of healthy humans. Clin Sci (Lond) 1996; 91:79-86.
150. Stabler SP, Allen RH, Dolce ET, Johnson MA. Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment. Am J Clin Nutr 2006; 84:1422-29.
151. Guerra-Shinohara EM, Morita OE, Pagliusi RA, Blaia-d’Avila VL, Allen RH, Stabler SP. Elevated serum S-adenosylhomocysteine in cobalamin-deficient megaloblastic anemia. Metabolism 2007; 56:339-47.
152. Wagner C, Koury MJ. Plasma S-adenosylhomocysteine versus homocysteine as a marker for vascular disease. JNutr 2008; 138:980; author reply 981.
153. Wagner C, Koury MJ. S-Adenosylhomocysteine: A better indicator of vascular disease than homocysteine? Am J Clin Nutr 2007; 86:1581-85.
154. Loehrer FM, Tschopl M, Angst CP, et al. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease. Atherosclerosis 2001; 154:147-54.
155. Herrmann W, Schorr H, Obeid R, Makowski J, Fowler B, Kuhlmann MK. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes. Clin Chem 2005; 51:891-97.
156. Wright AJ, Finglas PM, Dainty JR, Wolfe CA, Hart DJ, Wright DM, Gregory JF. Differential kinetic behavior and distribution for pteroylglutamic acid and reduced folates: A revised hypothesis of the primary site of PteGlu metabolism in humans. J Nutr 2005; 135:619-23.
157. Wright AJ, Dainty JR, Finglas PM. Folic acid metabolism in human subjects revisited: Potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr 2007; 98:667-75.
158. Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: Clinical aspects. Baillieres Clin Haematol 1995; 8:657-78.
159. Stabler SP, Lindenbaum J, Allen RH. Vitamin B-12 deficiency in the elderly: Current dilemmas. Am J Clin Nutr 1997; 66:741-49.
160. Mills JL, Von Kohorn I, Conley MR, Zeller JA, Cox C, Williamson RE, Dufour DR. Low vitamin B-12 concentrations in patients without anemia: The effect of folic acid fortification of grain. Am J Clin Nutr 2003; 77:1474-77.
161. Wyckoff KF, Ganji V. Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post folic acid fortification period than in the pre folic acid fortification period. Am J Clin Nutr 2007; 86:1187-92.
162. Herbert V, Bigaouette J. Call for endorsement of a petition to the Food and Drug Administration to always add vitamin B-12 to any folate fortification or supplement. Am J Clin Nutr 1997; 65:572-73.
163. Mills JL. Fortification of foods with folic acid—How much is enough? N Engl J Med2000; 342:1442-45.
164. Reynolds E. Folic acid fortification: Clarify the neurological risks. BMJ 2007; 335:171.
165. Oakley GP Jr. Let’s increase folic acid fortification and include vitamin B-12. Am J Clin Nutr 1997; 65:1889-90.
166. Dickinson CJ. Does folic acid harm people with vitamin B12 deficiency? QJM 1995; 88:357-64.
167. Tucker KL, Mahnken B, Wilson PW, Jacques P, Selhub J. Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. JAMA 1996; 276:1879-85.
168. Di Rocco A, Bottiglieri T, Werner P, Geraci A, Simpson D, Godbold J, Morgello S. Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy. Neurology 2002; 58:730-35.
169. Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W. Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem 2007; 53:1129-36.
170. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69:228-32.
171. Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP. Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: Relation with age and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2005; 76:1585-87.
172. Carmel R. Efficacy and safety of fortification and supplementation with vitamin B12: Biochemical and physiological effects. Food Nutr Bull 2008; 29:S177-87.
173. Clarke R, Grimley Evans J, Schneede J, Nexo E, Bates C, Fletcher A, Prentice A, et al.Vitamin B12 and folate deficiency in later life. Age Ageing 2004; 33:34-41.
174. Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, Schneede J, et al. Clinical relevance of low serum vitamin B12 concentrations in older people: The Banbury B12 study. Age Ageing 2006; 35:416-22.
175. Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc 2008; 9:162-67.
176. Dharmarajan TS, Adiga GU, Norkus EP. Vitamin B12 deficiency. Recognizing subtle symptoms in older adults. Geriatrics 2003; 58:30-34, 37-38.
177. Green R. Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies. Food Nutr Bull 2008; 29:S52-63; discussion S64-66.
178. Carmel R. Mean corpuscular volume and other concerns in the study of vitamin B-12 deficiency: Epidemiology with pathophysiology. Am J Clin Nutr 2008; 87:1962-63; author reply 1963-64.
179. Clarke R, Birks J, Nexo E, Ueland PM, Schneede J, Scott J, Molloy A, Evans JG. Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr 2007; 86:1384-91.
180. Berry RJ, Carter HK, Yang Q. Cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007; 86:265-67; author reply 267-69.
181. Yeung L, Yang Q, Berry RJ. Contributions of total daily intake of folic acid to serum folate concentrations. JAMA 2008; 300:2486-87.
182. Ray JG, Vermeulen MJ, Langman LJ, Boss SC, Cole DE. Persistence of vitamin B12 insufficiency among elderly women after folic acid food fortification. Clin Biochem2003; 36:387-91.
183. Brouwer I, Verhoef P. Folic acid fortification: Is masking of vitamin B-12 deficiency what we should really worry about? Am J Clin Nutr 2007; 86:897-98.
184. Morris MC, Evans DA, Bienias JL, Tangney CC, Hebert LE, Scherr PA, Schneider JA. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol 2005; 62:641-45.
185. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007; 85:193-200.
186. Smith AD. Folic acid fortification: The good, the bad, and the puzzle of vitamin B-12. Am J Clin Nutr 2007; 85:3-5.
187. Clarke R, Sherliker P, Hin H, Molloy AM, Nexo E, Ueland PM, Emmens K, Scott JM, Evans JG. Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br J Nutr 2008; 100:1054-59.
188. Selhub J, Morris MS, Jacques PF. In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Proc Natl Acad Sci USA 2007; 104:19995-20000.
189. Jackson IM, Doig WB, McDonald G. Pernicious anaemia as a cause of infertility. Lancet1967; 2:1159-60.
190. Hall M, Davidson RJ. Prophylactic folic acid in women with pernicious anaemia pregnant after periods of infertility. J Clin Pathol 1968; 21:599-602.
191. Bennett M. Vitamin B12 deficiency, infertility and recurrent fetal loss. J Reprod Med2001; 46:209-12.
192. Reznikoff-Etievant MF, Zittoun J, Vaylet C, Pernet P, Milliez J. Low vitamin B(12) level as a risk factor for very early recurrent abortion. Eur J Obstet Gynecol Reprod Biol2002; 104:156-59.
193. McLean E, de Benoist B, Allen LH. Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food Nutr Bull 2008; 29:S38-51.
194. Ray JG, Goodman J, O’Mahoney PR, Mamdani MM, Jiang D. High rate of maternal vitamin B12 deficiency nearly a decade after Canadian folic acid flour fortification. QJM 2008; 101:475-77.
195. Ronnenberg AG, Goldman MB, Chen D, Aitken IW, Willett WC, Selhub J, Xu X. Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am J Clin Nutr 2002; 76:1385-91.
196. Bondevik GT, Lie RT, Ulstein M, Kvale G. Maternal hematological status and risk of low birth weight and preterm delivery in Nepal. Acta Obstet Gynecol Scand 2001; 80:402-08.
197. Bondevik GT, Schneede J, Refsum H, Lie RT, Ulstein M, Kvale G. Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur J Clin Nutr 2001; 55:856-64.
198. Bruinse HW, van den Berg H. Changes of some vitamin levels during and after normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1995; 61:31-37.
199. Murphy MM, Molloy AM, Ueland PM, Fernandez-B allart JD, Schneede J, Arija V, Scott JM. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J Nutr 2007; 137:1863-67.
200. Koebnick C, Heins UA, Dagnelie PC, Wickramasinghe SN, Ratnayaka ID, Hothorn T, Pfahlberg AB, Hoffmann I, Lindemans J, Leitzmann C. Longitudinal concentrations of vitamin B(12) and vitamin B(12)-binding proteins during uncomplicated pregnancy. Clin Chem 2002; 48:928-33.
201. Hibbard ED, Spencer WJ. Low serum B12 levels and latent Addisonian anaemia in pregnancy. J Obstet Gynaecol Br Commonw 1970; 77:52-57.
202. Metz J, McGrath K, Bennett M, Hyland K, Bottiglieri T. Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal serum vitamin B12 levels. Am J Hematol 1995; 48:251-55.
203. Pardo J, Peled Y, Bar J, Hod M, Sela BA, Rafael ZB, Orvieto R. Evaluation of low serum vitamin B(12) in the non-anaemic pregnant patient. Hum Reprod 2000; 15:224-26.
204. Chery C, Barbe F, Lequere C, Abdelmouttaleb I, Gérard P, Barbarino P, Boutroy JL, Guéant JL. Hyperhomocysteinemia is related to a decreased blood level of vitamin B12 in the second and third trimester of normal pregnancy. Clin Chem Lab Med 2002; 40:1105-08.
205. Minet JC, Bisse E, Aebischer CP, Beil A, Wieland H, Lutschg J. Assessment of vitamin B-12, folate, and vitamin B-6 status and relation to sulfur amino acid metabolism in neonates. Am J Clin Nutr 2000; 72:751-57.
206. Molloy AM, Mills JL, McPartlin J, Kirke PN, Scott JM, Daly S. Maternal and fetal plasma homocysteine concentrations at birth: The influence of folate, vitamin B12, and the 5,10-methylenetetrahydrofolate reductase 677C-->T variant. Am J Obstet Gynecol 2002; 186:499-503.
207. Bjorke Monsen AL, Ueland PM, Vollset SE, Guttormsen AB, Markestad T, Solheim E, Refsum H. Determinants of cobalamin status in newborns. Pediatrics 2001; 108:624-30.
208. Obeid R, Morkbak AL, Munz W, Nexo E, Herrmann W. The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birth. Clin Chem2006; 52:263-69.
209. Bjorke Monsen AL, Ueland PM. Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence. Am J Clin Nutr 2003; 78:7-21.
210. Bjorke-Monsen AL, Torsvik I, Saetran H, Markestad T, Ueland PM. Common metabolic profile in infants indicating impaired cobalamin status responds to cobalamin supplementation. Pediatrics 2008; 122:83-91.
211. Ray JG, Blom HJ. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM 2003; 96:289-95.
212. Suarez L, Hendricks K, Felkner M, Gunter E. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol 2003; 13:81-88.
213. Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Wong PY, Farrell SA, Cole DE. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 2007; 18:362-66.
214. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, Scott JM, Mills JL. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 2009; 123:917-23.
215. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004; 350:2042-49.
216. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004; 350:2033-41.
217. Baines M, Kredan MB, Usher J, Davison A, Higgins G, Taylor W, West C, Fraser WD, Ranganath LR. The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone 2007; 40:730-36.
218. Cagnacci A, Bagni B, Zini A, Cannoletta M, Generali M, Volpe A. Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 2008; 42:314-20.
219. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS. Plasma total homocysteine level and bone mineral density: The Hordaland Homocysteine Study. Arch Intern Med 2006; 166:88-94.
220. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS. Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: The Hordaland Homocysteine Study. J Bone Miner Res 2007; 22:747-56.
221. Dhonukshe-Rutten RA, Lips M, de Jong N, Chin A Paw MJ, Hiddink GJ, van Dusseldorp M, De Groot LC, van Staveren WA. Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J Nutr 2003; 133:801-07.
222. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005; 20:921-29.
223. Dhonukshe-Rutten RA, van Dusseldorp M, Schneede J, de Groot LC, van Staveren WA. Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents. Eur J Nutr 2005; 44:341-47.
224. Tucker KL, Hannan MT, Qiao N, Jacques PF, Selhub J, Cupples LA, Kiel DP. Low plasma vitamin B12 is associated with lower BMD: The Framingham Osteoporosis Study. J Bone Miner Res 2005; 20:152-58.
225. Abrahamsen B, Jorgensen HL, Nielsen TL, Andersen M, Haug E, Schwarz P, Hagen C, Brixen K. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men—Results from the Odense Androgen Study. Bone 2006; 38:215-19.
226. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone 2005; 36:577-83.
227. Macdonald HM, McGuigan FE, Fraser WD, New SA, Ralston SH, Reid DM. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 2004; 35:957-64.
228. Steer C, Emmett P, Lewis S, Smith GD, Tobias J. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with spinal BMD in nine-year-old children. J Bone Miner Res 2009; 24:117-24.